Still not losing weight on Mounjaro after 3 months? Here's what's happening

Step 1: Work out where you are in the dose schedule

The first question worth asking honestly is which dose you're currently on. Mounjaro's licensed schedule runs from 2.5 mg up through 5, 7.5, 10, 12.5 and 15 mg, with increases typically every four weeks. The 2.5 mg pen exists to let your body adjust, nausea and GI discomfort are common early on, and the low starting dose reduces them. Weight loss at 2.5 mg is modest for most people, and that's by design.

If you're three months in and still on 2.5 or 5 mg because dose increases felt too rough, that's important context. The stronger appetite-suppressing effect builds gradually as tirzepatide accumulates at its target receptors. Many people see relatively little change in the first four to eight weeks, then a more noticeable shift once titration reaches a therapeutically active level. Check with your prescriber before drawing conclusions.

You can read a fuller breakdown of how quickly Mounjaro typically starts working on our page about how long Mounjaro takes to work, which covers the expected timeline by dose stage.

Step 2: Audit what's actually going into your body

Tirzepatide reduces appetite significantly for most people, but it doesn't make physics disappear. If your caloric intake has crept back up (because meals feel manageable again, because the appetite suppression is less intense at a lower dose, or simply because habits are hard) the medicine has less to work with.

A few things are worth checking honestly. Liquid calories (alcohol, juice, oat milk lattes) often go untracked. Restaurant portions are typically larger than home estimates. And when the nausea of early treatment fades, hunger can return quietly without feeling like hunger. Some people also find that soft, calorie-dense foods (the ones that slide past a slower stomach easily) become the path of least resistance.

This isn't about blame. Weight is shaped by biology as much as behaviour. But the medicine works alongside a reduced-calorie diet, not instead of one, and the clinical picture of not losing weight on Mounjaro almost always involves one of a small number of identifiable causes.

The NHS tirzepatide guidance is clear that Mounjaro is intended as part of a broader programme that includes dietary change and increased activity, neither is optional.

Step 3: Consider the factors outside your control

Some people have a slower response that has nothing to do with effort. Metabolic rate varies. Sleep quality affects hunger hormones independently of the medicine. Certain medications (some antidepressants, steroids, antipsychotics, some blood pressure drugs) are associated with weight gain or blunted response to weight-loss treatment, and a prescriber may not have the full picture unless you've flagged everything you're taking.

There's also the question of subcutaneous injection technique. Mounjaro is injected into the abdomen, thigh or upper arm, and rotating the site matters. Injecting repeatedly into the same spot can affect absorption. The pen should come from the fridge and be allowed to reach room temperature first (fifteen minutes or so, roughly the time it takes to make a cup of tea) before use.

For a broader look at what clinicians typically investigate when progress stalls, our guide for people who are wondering why they're on Mounjaro and not losing weight covers this territory thoroughly.

Step 4: Know when to take it back to your prescriber

Three months with minimal weight loss is a legitimate clinical conversation, not a personal failure. If you're at the highest dose you've tolerated and seeing less than 5% of your starting weight reduced after six months, NICE guidance (set out in TA1026, the appraisal of tirzepatide) recommends a formal review of whether continuing is appropriate. That's a prescriber's decision, not something to act on unilaterally.

What that review might involve: checking whether you're a candidate for a higher dose, discussing whether a different treatment approach fits better, or simply identifying a fixable barrier. There are also people for whom Mounjaro works well once the right dose is reached, but who stop early because the first months felt discouraging. If that sounds familiar, our dedicated resource for people who find themselves on Mounjaro but not losing weight walks through the most common barriers and what to do about them.

The SURMOUNT-1 trial (involving 2,539 adults over 72 weeks) recorded average weight reductions of around 20–21% at 15 mg, but those results accumulated over the full trial period, not the first quarter. Real-world outcomes from the 3-month Mounjaro mark look quite different from the 72-week endpoint.

If you're reviewing your options or want a clinical assessment of your current progress, you can start a free consultation with our prescribers. A named clinician (not an automated system) reviews every case. That's how a genuine clinical conversation starts.